Table 3.
Histopathological Profile of Patients With NAFLD (n = 60).
| Fibrosis stage | 0 | 16 (26.7%) |
| 1 | 23 (38.3%) | |
| 2 | 7 (11.7%) | |
| 3 | 9 (15%) | |
| 4 | 5 (8.3%) | |
| Ballooning grade | 0 | 42 (70%) |
| 1 | 13 (21.7%) | |
| 2 | 5 (8.3%) | |
| Lobular inflammation grade | 0 | 10 (16.7%) |
| 1 | 33 (55%) | |
| 2 | 15 (25%) | |
| 3 | 2 (3.3%) | |
| Steatosis grade | 0 | 0 |
| 1 | 19 (31.7%) | |
| 2 | 27 (45%) | |
| 3 | 14 (23.3%) | |
| NAS score ≥4 | 38 (63.3%) | |
| NASH | 17 (28.3%) | |
| Significant fibrosis (F ≥ 2) | 21 (35%) | |
| Advanced fibrosis (F ≥ 3) | 14 (23.3%) | |
| NASH + NAS ≥4 + F ≥ 2 | 11 (18.3%) | |
NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; NAS, NAFLD activity score.